<TABLE> <S> <C>


<ARTICLE>                       5
<LEGEND>
</LEGEND>
<CIK>                           0001057377
<NAME>                          Steroidogenesis Inhibitors International, Inc.
<MULTIPLIER>                                                    1,000
<CURRENCY>                                                 US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                                         DEC-31-2000
<PERIOD-START>                                            JAN-01-2000
<PERIOD-END>                                              SEP-30-2000
<EXCHANGE-RATE>                                                     1
<CASH>                                                             33
<SECURITIES>                                                        0
<RECEIVABLES>                                                      17
<ALLOWANCES>                                                        0
<INVENTORY>                                                         0
<CURRENT-ASSETS>                                                   50
<PP&E>                                                             47
<DEPRECIATION>                                                     23
<TOTAL-ASSETS>                                                    242
<CURRENT-LIABILITIES>                                             946
<BONDS>                                                             0
                                               0
                                                         0
<COMMON>                                                       11,428
<OTHER-SE>                                                    (12,383)
<TOTAL-LIABILITY-AND-EQUITY>                                     (955)
<SALES>                                                             0
<TOTAL-REVENUES>                                                    0
<CGS>                                                               0
<TOTAL-COSTS>                                                   6,569
<OTHER-EXPENSES>                                                    0
<LOSS-PROVISION>                                                    0
<INTEREST-EXPENSE>                                                  2
<INCOME-PRETAX>                                                (6,569)
<INCOME-TAX>                                                   (6,569)
<INCOME-CONTINUING>                                            (6,569)
<DISCONTINUED>                                                      0
<EXTRAORDINARY>                                                     0
<CHANGES>                                                           0
<NET-INCOME>                                                   (6,569)
<EPS-BASIC>                                                     (0.38)
<EPS-DILUTED>                                                   (0.38)



</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission